309 results
8-K
EX-99.1
ATR
Aptargroup Inc.
25 Apr 24
Aptar Reports First Quarter 2024 Results
5:24pm
for proprietary drug delivery systems are expected to be within the 7-11% long-term target range for the year, after exceptionally strong double-digit growth … Liabilities
Total Current Liabilities
Long-Term Obligations
Deferred Liabilities and Other
Total Liabilities
AptarGroup, Inc. Stockholders' Equity
8-K
EX-99.1
ah1o9 3do1o
8 Feb 24
Aptar Reports Fourth Quarter and Annual 2023 Results
5:04pm
8-K
EX-99.1
9uxi41jq
25 Oct 23
Aptar Reports Third Quarter 2023 Results
5:05pm
8-K
EX-99.1
e6ts125ueu
27 Jul 23
Aptar Reports Second Quarter 2023 Results
5:07pm
S-8
EX-4.3
c2wl4swn 8r
4 May 23
Registration of securities for employees
5:26pm
8-K
EX-10.1
41p5hwcbwfeddc
4 May 23
Departure of Directors or Certain Officers
4:06pm
DEFA14A
0364cim glpbd4
28 Apr 23
Additional proxy soliciting materials
5:05pm
8-K
EX-99.1
gey9p5cu54r3yvc4a3sg
27 Apr 23
Aptar Reports First Quarter 2023 Results
5:02pm
8-K
s7sz226e7jy6gojvvvt
13 Apr 23
Regulation FD Disclosure
9:41am
8-K
EX-99.1
gfe7cnay
27 Oct 22
Aptar Reports Third Quarter 2022 Results
5:02pm